Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.94 USD | +6.70% | +14.88% | -61.63% |
Apr. 18 | Sector Update: Health Care Stocks Ease in Afternoon Trading | MT |
Apr. 18 | Moleculin Biotech Secures Orphan Drug Label For Annamycin in EU | MT |
- Stock Market
- Equities
- MBRX Stock
- News Moleculin Biotech, Inc.
- MarketScreener Strategies